Picture EBD Group BioTech Showcase 2021 Digital Event BTS2021 651x81
Document › Details

Ynsect S.A.. (3/4/14). "Press Release: Ynsect Raises 1.8 Million Euro in Series A Funding to Develop Insect Biorefineries".

Organisations Organisation Ynsect S.A.S.
  Organisation 2 Emertec Gestion S.A.
  Today Demeter Ventures
  Group Demeter (Group)
  Product 2 venture capital
Index term Index term Ynsect–SEVERAL: investment, 201403 financing round Series A €1.8m from Emertec Gestion + Demeter Partners + private investors

YNSECT, the insect biotech startup, has closed its Series A round of €1.8M from the major biotech and clean tech venture capital funds EMERTEC Gestion and DEMETER Partners, as well as private investors.

YNSECT develops large-scale insect rearing technologies, and the recovery and processing of high value molecule streams. The company, which has been working on industrial solutions for thirty months, focuses on developing high-value applications for its first products (nutraceuticals, cosmetics, advanced bio-based chemicals…) and on feed applications as a second step. This first round of 1.8M€ will allow YNSECT to keep developing technological value with an ambitious R&D program, to deploay its production pilot and to win its first markets.

The context of YNSECT activities gathers two major trends: the development of sustainable alternative bio-based products and the urge to increase protein production for food and feed. Insects are currently an underused sustainable resource, and YNSECT aims to answer both these challenges by using insects at their fullest potential.

"It is a great pleasure and a great honor to work with EMERTEC Gestion and DEMETER Partners, as they are two European leader venture capital funds specialized in Biotech and Clean Tech. This operation is a first in Europe, by the technical and financial quality of our new shareholders, as well as the size of their commitment. We believe it is a strong signal showing that the industry recognizes and understands the market potential of insect biotech. Our technologies use highly technical processes, and produce material for high value-added applications. Our products are eagerly awaited both by specialty chemistry and feed markets" comments Antoine Hubert, President of YNSECT.

"YNSECT introduces insects in the industry as an innovative technological biodiversity, and create commercial opportunities unseen yet. The quality of its team and its biorefinery-based strategy are fantastic assets in a domain which earns a growing interest worldwide. EMERTEC decided to follow the company by bringing half of the funds of this Series A funding via its new seed fund EMERTEC 5", explains Franck Lamy, Investment Director at EMERTEC.

"Ambitious R&D Program, optimization of rearing technologies, industrial strategy gathering prominent partners, research on high value-added molecules, YNSECT approach is really innovative and unique amongst insect companies. DEMETER is thrilled to support this team of dynamic, talented, and complementary team of entrepreneurs with its seed fund DEMETER 3" declares Olivier Dupont, Chairman of Board of DEMETER.


YNSECT was founded at the end of 2011 by Antoine Hubert, Jean-Gabriel Levon, Fabrice Berro and Alexis Angot. YNSECT has developed partnerships with major research centers in France and Europe (IFREMER, INRA, CNRS, CEA, AgroParisTech, IRSTEA, Wageningen University…) and coordinates the project DESIRABLE, which was selected and financed by the French National Research Agency. The company is also supported by Bpifrance and Région Île-de-France. The company is also an active member of competitiveness clusters, such as IAR and Vitagora, as well as the expert consultancy committee on insects of the FAO. YNSECT was hosted at the company incubator Agoranov and is the laureate of the 2012 French National Award of Agri-food Startups of Agropole, of the 2013 John Sime Innovation Award at the European Forum of Industrial Biotechnology and of the 2013 National Award of Biotech Startup of Genopole. Press contact: Mr. Alexis Angot -

About EMERTEC Gestion:

Founded in Grenoble in 1999, EMERTEC is a venture capital firm with €150M under management, raised from the support of institutional investors and large industrial companies. Focusing on early stage investments in Cleantech technologies, the FCPR EMERTEC 5 was raised with the support of the "National Seed Fund" (Fonds National d'Amorcage) managed by Bpifrance Investissement as part of the PIA Program, and the European Investment Fund through the European Union Competitiveness and Innovation Framework Program (CIP). Contact: Franck Lamy -

About DEMETER Partners:

Demeter Partners venture capital firm which focuses on environment and renewable energy technologies. Currently endowed with €350M, it invests in young European companies (primarily French, German and Spanish companies) within the eco-industries and the eco-energies at several stages, from seed to growth funding rounds. The FCPR Demeter 3 Seed Fund was raised with the support of the European Investment Fund through the European Union Competitiveness and Innovation Framework Program (CIP) and the "National Seed Fund" (Fonds National d'Amorcage) managed by Bpifrance Investissement as part of the PIA Program.


Legal: Ynsect / Kahn & Associés (Olivier Cognard & Liên Lê), Investors / Joffe & Associés (Thomas Saltiel & Virginie Belle).

Audit: PKF (Sylvain Lavagnat)

Record changed: 2016-01-10


Picture Kentro Design Corporate and Web Design Berlin 650x65px

More documents for Ynsect S.A.S.

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture EBD Group Digital Medicine & Medtech Showcase 2021 at BTS2021 651x81

» top